A new efficient method for SAXS-driven simulations allows researchers to explain the dynamics of linear polyubiquitin.
Abstract
Polyubiquitin chains are flexible multidomain proteins, whose conformational dynamics enable them to regulate multiple biological pathways. Their dynamic is determined by the linkage between ubiquitins and by the number of ubiquitin units. Characterizing polyubiquitin behavior as a function of their length is hampered because of increasing system size and conformational variability. Here, we introduce a new approach to efficiently integrating small-angle x-ray scattering with simulations allowing us to accurately characterize the dynamics of linear di-, tri-, and tetraubiquitin in the free state as well as of diubiquitin in complex with NEMO, a central regulator in the NF-κB pathway. Our results show that the behavior of the diubiquitin subunits is independent of the presence of additional ubiquitin modules and that the dynamics of polyubiquitins with different lengths follow a simple model. Together with experimental data from multiple biophysical techniques, we then rationalize the 2:1 NEMO:polyubiquitin binding.
INTRODUCTION
Ubiquitination is a reversible posttranscriptional modification system that regulates key physiological processes, such as protein degradation, cell cycle, apoptosis, DNA repair, and signal transduction (1–3). Once a protein substrate is monoubiquitinated (e.g., a lysine of the substrate is conjugated through an isopeptide bond to the C terminus of a ubiquitin monomer), an additional ubiquitin may be conjugated to either one of the seven lysine residues of the first ubiquitin (K6, K11, K27, K29, K33, K48, and K63) (4) or its N-terminal methionine residue (M1) (5–7). This process can lead to the assembly of polyubiquitin chains of various lengths and topologies. The resulting polymeric chains are then associated with different cellular mechanisms (8). Since all these polymers are made of the same single unit, the highly conserved 76-residue-long ubiquitin domain, the ubiquitin code is an example of a conformation-based alphabet, where both the polymerization site (8, 9) and the chain length (10) regulate the recognition by different partners and thereby determine the cellular fate of the protein. The role of polyubiquitin length and dynamics in molecular recognition processes is poorly understood (8, 10, 11). An overall assessment of the typical length of different polyubiquitin chains in physiological conditions is missing, and only sporadic indications are available. For example, in the case of K48-linked polyubiquitin, a length of four is generally considered optimal for molecular recognition of the 26S proteasome (12), while the nuclear protein localization protein 4 is selective for K48-linked chains longer than six (13). It was reported that K48-linked tetraubiquitin (Ub4) slows down further ubiquitination (14–16), while this is not the case for K63-linked Ub4 (16).
Linear M1-linked polyubiquitin chains (Fig. 1), whose assembly is catalyzed by linear ubiquitin chain assembly complex (LUBAC) (5), have been shown to play a role in inflammation, immune responses, and oncogenesis (17–19). Their most studied function is the involvement in the activation of the canonical nuclear factor κB (NF-κB) pathway (6, 7, 17, 20–23). In this pathway, the IKK complex [or IκB (inhibitor of the NF-κB proteins) kinase, formed by IKKα, IKKβ, and NEMO, also known as IKKγ, the NF-κB essential modulator] is activated by LUBAC upon activation by various stimuli (22). LUBAC preferentially recognizes and conjugates linear ubiquitin chains on NEMO. NEMO also has a specific linear diubiquitin-binding region referred to as the “ubiquitin binding in A20-binding inhibitor of NF-kappa-B activation (ABIN) and NEMO” (UBAN) motif (24), which forms a helical coiled-coil dimer in solution (23). Recognition of a linear polyubiquitin conjugated to NEMO by the UBAN domain of another NEMO may trigger the clustering of the IKK complex and conformational changes that subsequently activate IKK (25, 26). Once active, IKK can phosphorylate and inactivate the IκBs, leading to the release of NF-κB (27). It was recently shown that it is possible to inhibit NF-κB activation upon UBAN-dependent tumor necrosis factor–α and T cell receptor/CD28 stimulation by small molecules that inhibit the binding of linear polyubiquitins to the NEMOUBAN domain (23). While the NEMOUBAN domain can bind linear diubiquitin, it has been observed that full-length NEMO can only bind Ub4 or longer, suggesting a length-dependent activation mechanism (21). Furthermore, another study suggested that the binding of NEMO to chains of 10 linear ubiquitins or longer induces a different conformation of NEMO compared to the binding of shorter chains (20).
Characterizing the conformational space of polyubiquitin chains as a function of length is critical to understand their physiological behavior. Such structural characterization is nonetheless very challenging. Polyubiquitins, from diubiquitin to longer chains, exhibit a very dynamic behavior (28) that requires determining a statistical ensemble of all the relevant configurations populated in solution. The combination of molecular dynamics (MD) with experimental small-angle x-ray scattering (SAXS) data is very well suitable to study dynamic protein systems (29) including polyubiquitin of varying chain size. SAXS does not provide high-resolution structural information. Conversely, MD simulations may be used to determine the statistical ensemble of configuration populated by a system in equilibrium condition, but a full modeling base on MD simulations is hampered by the size of the system (30, 31). This problem can, in principle, be alleviated by coarse-grain force fields (32), eventually combined with enhanced sampling techniques (33), that can massively speed up MD simulations although potentially at the expense of the accuracy (32).
Here, we show that by integrating SAXS and MD simulations based on the Martini coarse-grain force field (34, 35) by means of metainference (36), we can efficiently generate an ensemble of structures representing the dynamics of linear polyubiquitins (Fig. 1). The ensembles allow the description of the dynamics of these complex systems at the single-residue level. Our results show how polyubiquitins can populate multiple conformational states but unexpectedly indicate that linear polyubiquitin chains and potentially polyubiquitins, in general, can be described by a simple self-avoiding polymer model. Various biophysical experiments are used to characterize the stoichiometry, kinetics, and thermodynamic properties of the binding of polyubiquitin to the NEMOUBAN domain. Unexpectedly, our data demonstrate that NEMOUBAN binds to di-, tri-, and tetraubiquitin (Ub2, Ub3, and Ub4) in all cases forming a 2:1 NEMOUBAN:UbN complex in solution. Notably, a conformational ensemble for the NEMOUBAN:Ub2 complex rationalizes the 2:1 binding. Combined with our proposed polyubiquitin polymer model, this suggests how longer polyubiquitin chains may modulate NEMO recognition as well as bind more than one NEMO dimer.
RESULTS
A simple Martini modification improves the simulation of linear diubiquitin
We first evaluated the ability of the Martini coarse-grain force field to describe the dynamics of a linear Ub2. A metadynamics (37) simulation of Martini Ub2 resulted in an extremely compact ensemble of structures (Fig. 2A), which does not reproduce the measured SAXS intensities (Fig. 2D and fig. S1). In Fig. 2A, we report a free energy landscape (in kilojoules per mole) as a function of the distance between the centers of the two ubiquitin domains and their relative orientation; the average distance between the two domains is very short, around 2.41 ± 0.02 nm, with a preferential orientation of the two ubiquitin’s domain (measured as the torsion angle between two axes defined using the first and second half of the sequence of each ubiquitin; cf. Methods). The average radius of gyration of 1.73 ± 0.01 nm strongly underestimates the value of 2.23 ± 0.02 nm derived from SAXS (fig. S1). The ensemble seems to be able only to capture compact Ub2 configurations also when compared to the available crystal structures [PDB (Protein Data Bank) 2W9N (38) (open), 3AXC (39) (compact), and 4ZQS (28) (compact)]. This result is not unexpected for the Martini force field, and both weakening the protein-protein interactions (40, 41) and increasing the protein-solvent interaction (42, 43) have been suggested as possible solutions. A more complex water model, such as the Martini polarizable water (44), is also available, but at the expense of performance. Recent developments in atomistic force fields demonstrated the need for tuning solute-solvent interactions (45, 46). Following recent approaches that have successfully improved atomistic and coarse-grained (CG) force fields, we repeated the same simulation after increasing by 5% the Martini water-protein Lennard-Jones interaction. This simple adjustment was sufficient to obtain a more expanded ensemble of structures as shown by the free energy landscape (Fig. 2B), without any additional computational cost (fig. S2). The new ensemble resulted in an improved, even if not yet quantitative, agreement with the SAXS data (Fig. 2D, blue curve, and fig. S1). The average distance between the domains increased to 3.10 ± 0.02 nm, and the protein can explore a much wider conformational space that now includes open and closed structures. In terms of the radius of gyration, the ensemble average resulted in 2.05 ± 0.01 nm to be compared with the 2.23 ± 0.02 nm derived from SAXS. Of note, comparing the free energy surface of the underdevelopment version of the Martini force field (Martini 3, currently in beta phase) with Martini 2.2 shows promising behavior by exploring more open conformation but may still benefit from increased protein-water (P-W) interaction (fig. S2). Nonetheless, our aim here is to obtain ensembles in quantitative agreement with the SAXS data without a large-scale force field reparameterization effort. This can be achieved at least, in principle, by integrating experimental information directly in the simulation by metainference (36). To show this, we run metadynamic metainference (M&M) (47) simulations (see Methods) with the K63-linked Ub2 and compared them with published atomistic ensembles (fig. S3). In Paissoni et al. (48), an ensemble of K63-linked Ub2 was generated through atomistic simulation with integrated SAXS data and validated against nuclear magnetic resonance (NMR) data. Overall, our energy landscape and the distribution of the radius of gyrations are comparable to the atomistic ones. The global minima region of the free energy landscape is correctly identified (red box in fig. S3), with a substantial improvement over an unrestraint atomistic ensemble (48). However, the modified Martini force field fails to correctly identify the conformation of very compact states (which are missing in the unrestrained atomistic ensemble). Comparing the contact maps shows that our approach still manages to identify the correct interdomain contact regions while being less specific. A weakening of the elastic network, which stabilizing the core of ubiquitin subunits (see Methods), or a further increase of the P-W interaction does not lead to improvement (fig. S4). A simple excluded volume model with integrated SAXS data is not sufficient to achieve qualitatively similar free energy surface (fig. S3). This shows that at least a qualitatively accurate description of the interdomain interactions is necessary to generate a precise SAXS ensemble.
Overall, our approach of coupling a modified Martini force field with SAXS manages to capture the overall balance between the compact and open states. It allows us to identify the global minima conformations and interdomain contact regions, but it might fail to capture specific compact states accurately. While a restrained atomistic simulation can lead to more accurate results, having a few hundred times faster sampling (fig. S2E) is a substantial benefit, making the sampling of more extended ubiquitin chains systems accessible.
Metainference SAXS simulations of Martini linear diubiquitin quantitatively reproduce the experimental data
M&M (47) simulation (see Methods) for Martini linear Ub2 (including our modified water) result in an ensemble of configurations characterized by a flatter and broader free energy landscape (Fig. 2C) and in quantitative agreement with the experimental SAXS (Fig. 2, D and E, and fig. S1). With respect to the unrestrained simulation, the average distance between the two domains increased from 3.10 ± 0.02 nm to 3.32 ± 0.02 nm. The radius of gyration of the ensemble of 2.23 ± 0.01 nm quantitatively agrees with that derived from SAXS of 2.23 ± 0.02 nm. Qualitatively, the topology of the free energy landscape is comparable to the unrestrained simulation but translated to larger relative distances. Overall, the free energy landscape is quite flat with relatively limited free energy differences indicating that the two ubiquitin domains are relatively free to move with respect to each other. Therefore, Ub2 shows highly dynamical behavior, which cannot be described by a few individual structures. Instead, a full ensemble is required in agreement with previous findings on linear as well as other diubiquitins.
From the performance point of view, the SAXS on-the-fly calculation used by metainference is computationally demanding, but the use of a CG representation makes it far more affordable with respect to the same simulation performed at full atomistic resolution (fig. S2). The loss of performance resulting from the use of SAXS is justified by the increased accuracy of the resulting simulations. Note that it is not required to calculate the metainference SAXS restraint at every step of the simulation. By calculating it every five steps, we obtained a quantitatively equivalent ensemble at a fraction of the computational cost (fig. S2). Notably, using metainference allows us also to sample the scaling value, which is necessary to compare the experimental and computed SAXS curves. For Ub2, we observed a 3% higher scaling value for the simulation with increased P-W interaction and a 9% higher scaling value just with the Martini force field compared to the metainference solution (fig. S1).
Linear polyubiquitin chains are preferentially extended, do not show long-range correlations, and can be described as self-avoiding polymers
To investigate the dynamics of linear Ub3 and Ub4, we performed SAXS experiments on both proteins at different concentrations (fig. S5). The measured SAXS data were then used to perform M&M simulations (cf. Methods and table S1). In addition, unrestrained simulations based only on Martini with our modified water were also performed. In Fig. 3 (see also fig. S1), we show the comparison of the back-calculated SAXS with respect to the experimental measures of Ub3 and Ub4. The effect of our improved water diminishes for the longer polyubiquitin chains. A comparison of the radius of gyration for the Ub2, Ub3, and Ub4 ensembles show that while the unrestrained and restrained simulations sample a comparable range of compactness, the restrained simulations are shifted toward a more extended conformational space. The trend of the average radius of gyration (2.0, 2.7, and 3.3 nm for Ub2, Ub3, and Ub4, respectively; cf. Methods and fig. S1A) suggests an almost linear increase of the size of the protein with the number of ubiquitin monomers. The analysis of the free energy landscape for the Ub2 couples in Ub3 and Ub4 (fig. S6) qualitatively shows the same behavior, suggesting that the interdomain interactions are essentially only those between neighbor domains (i.e., between Ub2). For Ub3 and Ub4, this is confirmed by analyzing the free energy landscape of non-neighbor ubiquitin domains. Overall, the free energy landscape is flatter for larger polyubiquitin chains, indicating that the interaction with neighboring ubiquitin becomes less and less specific. Also, the distance (centers of the two ubiquitin domains) distribution shifts from a bimodal distribution for Ub2 to a flatter one for Ub3 and Ub4. We also observe that Ub3 samples more extended conformations for large distances >4.0 nm, while both Ub4 and Ub3 are forming more compact conformation below 2.6 nm. In fig. S7 (A to C), the free energy profiles are shown for the first-and-third ubiquitin Ub3(1-3) in Ub3 as well as for the first-and-third Ub4(1-3) and second-and-fourth Ub4(2-4). These landscapes are all qualitatively similar showing that the interaction between two non-neighbor ubiquitins is quite rare. The average distance between a 1-3 and 2-4 ubiquitin pair is around 6 nm, with an average angle of around 140°. The first ubiquitin does not influence the relative orientation of the third ubiquitin. The first-and-fourth Ub4(1-4) ubiquitin couple, as shown in fig. S7D, behaves similarly. Interactions between the first and fourth ubiquitin are also rare. In most cases, the distance between both ubiquitins is around 8.5 nm. There is also no strong preference for a specific torsion angle between all four ubiquitins.
To further assess the presence of short and long-range interactions between neighbor and non-neighbor ubiquitin couples, we estimated the fraction of compact configurations by analyzing the minimum distance between neighbor and non-neighbor ubiquitin couples (Fig. 4, A and B). For neighbor and non-neighbor couples, there is a peak in the distribution around 0.5 nm. As already indicated by the free energy profiles, compact neighbor ubiquitin pairs represent around 40 to 50% of the ensemble, while contacts between non-neighbor couples are only present in around 8% for Ub3 and around 2% for Ub4, indicating an overall lack of compact states in linear polyubiquitins. A contact analysis for the Ub2 compact state indicates that this state is not structurally homogeneous. Even the most frequent contact is only present in 10 to 30% of all compact conformations, depending on the specific ubiquitin pair (Fig. 4C). On the other hand, even the 10th most frequent contact has still a probability between 5 and 15%, while the 100th most frequent one is still in the 1 to 5% range.
Nonetheless, all residues involved in the most frequent contacts belong to three distinct surfaces. These interactions define the preferred orientations between two adjacent ubiquitin pairs. All residues involved in the most frequent contacts from the first ubiquitin are on the same surface as the hydrophobic patch I44 (Fig. 4D), which is known to be also essential for interactions of ubiquitin with other proteins. The hydrophobic patch is also the main contributor for the interdomain contacts in the K63 Ub2 (fig. S3). This result is consistent between atomistic and coarse-grain simulation. The I44 surface interacts either with the surface around E182 or I132 (E18 or I13 would be the analog residues of the first ubiquitin). The E182 surface is located opposite to the I44 surface, while the I132 surface is roughly 90° rotated to the I44 and E182 surface. In fig. S6 (H to M), the 10 most frequent contacts between ubiquitin cores for all adjacent ubiquitin pairs are illustrated. Ub2 is predominantly stabilized by salt bridges between the positive charged R42 and K48 and the negative charged E162 and E182. However, going to Ub3 and Ub4, electrostatic interactions become less important compared to van der Waals (vdW) interactions (fig. S7F). For Ub2, the Coulomb interaction between charged amino acids is responsible for 27% of the total interaction energy between two ubiquitin cores. This value goes as low as 9% for the Ub (3-4) pair of Ub4. Since the Martini force field has limitations in terms of electrostatics, the absolute ratios between vdW and Coulomb interactions are likely not meaningful. However, since our modified Martini force field with SAXS data manages to capture the important interaction regions, the relative changes between different ubiquitin pairs are likely qualitatively correct. The lower electrostatic interactions may also explain the flatter free energy surfaces of Ub3 and Ub4 neighbor pairs (fig. S4). On the other hand, the increased role of vdW interactions in Ub3 and Ub4 is compatible with the increase in the compact population of diubiquitin couples. Last, while in Ub2 the I44 surface prefers to interact with the E182 surface, interactions between the I44 and the I132 surface are more important for the last pair of Ub4, causing a shift of the preferred orientation between both ubiquitins.
Overall, our linear Ub2, Ub3, and Ub4 ensembles indicate that linear polyubiquitins are extended polymers, whose dynamics are mostly uncorrelated over a distance of more than one ubiquitin domain. In Fig. 4E, this behavior is further highlighted by plotting the end-to-end distance as a function of the number N of ubiquitin domain, e2e(N). Fitting the data with a power law (including the end-to-end distance for Ub1) resulted in e2e(N) = 3.81N0.62 in remarkable agreement with Flory theory for self-avoiding polymers (49). This is remarkable, since generally, proteins do not behave as self-avoiding chain, showing also less entropy in the denatured state. This behavior is not shown in simulations just with increased P-W interactions, which have a substantially lower exponent of 0.36. It is tempting to speculate that all polyubiquitins may be described as self-avoiding polymers following the same relationship for the end-to-end distance but with a different prefactor (i.e., characteristic length) associated with the distance between the C-terminal glycine and the specific linkage side chain. For K63-linked polyubiquitins, we could test this, even if only with the monoubiquitin and diubiquitin, making use of a SAXS-based ensemble that we recently published (48). By fixing the exponent to 0.6 and setting the prefactor to the average distance between the C terminus and K63, the expected e2e distance of Ub2 fits the ensemble. This suggests that the fit can be used to predict the behavior for longer K63-linked UbN chains (fig. S6). Extrapolating for other linkages, we observe that K11- and K48-linked polyubiquitin, which are known to populate more compact states in solution (50, 51), have a shorter distance between the C terminus and the lysine and would consequently show smaller prefactors and populate systematically more compact states than K63- and M1-linked.
The conformational entropy of long linear polyubiquitins modulates NEMO binding
To study the dynamics and changes of linear polyubiquitin dynamics upon binding to cognate proteins, we used simulations and experiments to characterize the interaction of the NEMO UBAN domain (NEMO258–350) to the linear polyubiquitins Ub2, Ub3, and Ub4. The NEMO UBAN domain is a dimer in solution (23). Previous studies have shown two different binding stoichiometries in solution and crystalline state for Ub2: with either two NEMO monomers bound to one Ub2(2:1) or two NEMO monomers bound to two Ub2 (2:2) (23, 24). Polyubiquitin chains longer than Ub2 harbor potentially more than one binding site and could thus bind more than one NEMO dimer with a theoretical stoichiometry for UbN of 2(N − 1):1 (NEMO:UbN). A crystal structure (PDB 5H07) shows the binding of two linear Ub3 to four ABIN monomers (a homolog of NEMO that also forms a dimer in solution) (52). The observed binding mode requires Ub3 to be in a relatively compact and univocally oriented configuration to avoid steric hindrances between the two ABIN dimers. This would markedly decrease the entropy not only of each diubiquitin couple but also that of the overall chain and thus should be entropically disfavored in solution (fig. S7). Isothermal titration calorimetry (ITC) experiments show that in solution, only one ABIN dimer binds to Ub3 (52), arguing that higher stoichiometries are artifactual, induced by crystal packing, and do not reflect the solution assembly.
To characterize the binding in solution of NEMO to Ub3 and Ub4, we performed SAXS (Fig. 5 and fig. S5), ITC (Fig. 5 and fig. S9), size exclusion chromatography (SEC) coupled with static light scattering (SLS) (Fig. 5, fig. S9, and table S2), and surface plasmon resonance (SPR) (fig. S9). Extending Ub2 to Ub3 and Ub4 does not affect the (2:1) binding stoichiometry, with either polyubiquitin protein binding two NEMO monomers (one NEMO dimer) (Fig. 5). In SEC experiments with SLS, we detected NEMO:Ub3 complexes with molecular weights (MWs) ranging from 41 to 45 kDa, which is similar to the MW of the calculated 2:1 NEMO:Ub3 complex (47.7 kDa), while for NEMO:Ub4 complexes only a single peak is found with MW between 53 and 56 kDa (calculated MW 2:1 NEMO:Ub4, 56.2 kDa). SAXS measurements confirmed the stoichiometry observed by SLS-SEC. ITC indicates that NEMO binds to Ub3 and Ub4 with very similar enthalpy (ΔH of −17.9 and −18.8 kJ/mol, respectively), suggesting that the molecular interactions and binding interfaces between NEMO and the different polyubiquitins are similar to the one described for NEMO:Ub2 (23) (ΔH of −16.9 kJ/mol). Affinities for Ub3 and Ub4 are 1.6 and 4.1 μM close to 1.8 μM obtained for Ub2. ITC data comparing shorter and longer polyubiquitins may suggest that longer polyubiquitins can form long-range, flanking interactions with NEMO, resulting in a gain of enthalpy and loss of entropy with respect to shorter ones. SPR confirmed the binding between NEMO and Ub3 and Ub4 with equilibrium dissociation constants (KD) of 9.6 and 6.4 μM for Ub3 and Ub4, respectively.
To explain the contradictory observation of the stoichiometry in solution and in crystal and to better understand the molecular recognition between linear polyubiquitins and NEMO, we characterized the dynamics of a NEMO258–350:Ub2 complex. An M&M Martini simulation was performed including SAXS data for the complex previously measured (Fig. 6A and fig. S10). The resulting ensemble of structures highlights how binding to NEMO strongly decreases the conformational freedom of linear Ub2 (Figs. 2 and 6A). Neither the ensemble nor the crystal structures of other bound Ub2 are located close to the minima of the free Ub2 ensemble, which has a different distance and orientation between both ubiquitins. Ub2 residues building up the NEMO258–350:Ub2 interface overlap with those involved in the interdomain interactions (fig. S10), in particular residues around the hydrophobic patch I44 and the previously mentioned E182 surface. The observed interaction sites are in agreement with observed NMR chemical shifts perturbations reported in Vincendeau et al. (23). The ensemble also provides a possible explanation for the different binding stoichiometry observed in solution (NEMO:Ub2 2:1) and crystalline state (NEMO:Ub2 2:2). A detailed analysis of the NEMO-binding sites indicates that almost all the residues of the NEMO unoccupied site are less exposed to the solvent than those on the occupied one (fig. S10H). While the solvent accessible surface area of the occupied site is 13 nm2, the one of the unoccupied is 11.9 nm2, showing that both binding sites are not equal after the binding of Ub2. Together, these observations indicate that, in solution, binding of linear Ub2 to NEMOUBAN induces allosteric effects that modulate the overall structure and dynamics of the NEMO dimer. These observations also suggest that the 2:2 highly symmetric binding mode observed in the dense and ordered crystalline state becomes entropically unfavorable to the more flexible and far less dense solution state of the complex.
DISCUSSION
Structural biology investigations on polyubiquitins have mostly focused on diubiquitins, observing that different protein linkages correspond to different protein dynamics leading to different exposed regions for the binding with partners (48, 50, 51, 53–59). Ubiquitin signaling has been found associated not only to the linkage type but also to the length of the ubiquitin chains (8–10). Here, we first develop an efficient and accurate integrative approach to characterize the conformational ensembles of linear polyubiquitin by combining the Martini coarse-grain force field with SAXS experiments in the framework of metainference. We then use our method to try to rationalize the length-dependent behavior of linear polyubiquitins and the consequence for the interaction with their partner NEMO. Figure 6 rationalizes the observed differences in binding by comparing our free UbN ensembles with our NEMO-bound ensemble. The fraction of bound-like configurations in the Ub2 ensemble is a small fraction of the total ensemble, suggesting a large conformational entropy loss upon binding. This is likely compensated by a release of a large number of water molecules from the binding interfaces upon binding to result in a final entropy gain as indicated by ITC (Fig. 5). The probability of finding at least one diubiquitin pair in a bound-like configuration in the Ub3 and Ub4 ensemble increases slightly more than linearly (3.2, 6.7, and 12.0% for Ub2, Ub3, and Ub4, respectively), suggesting that longer polyubiquitins are likely to more favorably bind NEMO with respect to shorter ones. The SEC-SLS experiments show that NEMO bound to Ub4 eluted as a single bound peak in comparison with Ub3 (table S2 and fig. S9, D and E). Since both NEMO:Ub4 and NEMO:Ub3 have similar KDs, this can indicate a difference in kinetic stability. To provide a structural interpretation for this hypothesis, we calculated the actual probability of finding the full polyubiquitin in a configuration compatible with the binding (and thus avoiding configurations that would lead to a steric clash with NEMO (Fig. 6, B to D) from our free polyubiquitin ensembles. The probability decreases from Ub2 to Ub4 (3.2, 1.5, and 1.4% for Ub2 Ub3, and Ub4, respectively), which can lead to entropy loss. At the same time, nonspecific flanking interactions between polyubiquitin and NEMO far from the binding site can increase the enthalpy. This is also in agreement with previous measures where, using a longer NEMO construct (NEMO242–419) that could provide more surface for interactions, affinities of 3 and 0.3 μM were reported for Ub2 and Ub4, respectively (60). This principle is also common for intrinsically disordered proteins possibly modulating the lifetime of complexes (61). These long-range effects would be less pronounced for a less entropic chain and can play a length-dependent role in the overall interaction.
The probability of finding two diubiquitin pairs in a bound-like configuration is essentially negligible for both Ub3 and Ub4 providing a rationale why a 2:1 NEMO258–350:Ub4 interaction is favored by entropy with respect to the 4:1. Making use of our polymer model, we can also speculate that a long-enough polyubiquitin may be able to bind two NEMO dimers with a higher-order (i.e., 4:1) stoichiometry with respect to the 2:1 observed for the Ub2 to Ub4 range. Given that the end-to-end distance of Ub2 corresponds to one-half of that of our NEMO construct (5.8 nm for Ub2 and 11.4 nm for NEMO), and that the two Ub2 units that bind the two NEMO should be allowed to be flexible, one can estimate the length of this polyubiquitin to be such that e2e(N − 2) ≥ 11.4 nm. This results in a minimum length of N = 8 ubiquitins. While this result will not be quantitative when considering a full-length NEMO, it suggests a possible need for these long chains in the assembly of the IKK complex.
Conclusions
The combined use of experiments and MD simulation is a powerful tool to investigate the structure and dynamics of biomolecules and provide a ground for the functional interpretation of protein dynamics. Here, we combined SAXS and CG Martini simulations to accurately and efficiently study the conformational dynamics of linear polyubiquitins and their binding to NEMO. The resulting conformational ensembles allowed us to propose that linear polyubiquitin behave as self-avoiding polymer chains. This might also apply for polyubiquitins in general (with different characteristic lengths). Combining structural studies with multiple biophysical experiments, we provide a systematic assessment of the effect of the polyubiquitin chain length in the molecular recognition of cognate proteins, suggesting that polyubiquitin may modulate the binding with their partners in a length-dependent manner.
METHODS
CG MD simulations
CG MD (CG-MD) simulations were applied to investigate the dynamic of linear di-, tri-, and tetraubiquitin (Ub2, Ub3, and Ub4), as well as Ub2 with bound NEMO. In total, 11 different simulations have been performed with a total simulation length of 780 μs. An overview of all simulations can be found in table S1.
All CG simulations were run using Gromacs 2016.3 (62) and the Martini force field (34, 35). In addition, an elastic network model with a force constant of 500 kJ mol−1 nm−2 was used to conserve the secondary and tertiary structure (34, 63). In the case of polyubiquitin, the elastic network inside was only defined for the backbone beads of the core region (from residues 1 to 70, 77 to 146, 153 to 222, or 229 to 298) and not between different domains nor for the linker region. All simulations were performed with periodic boundary conditions, and the systems were solvated with a 0.1 M NaCl solution and run as an isothermal-isobaric (NpT) with a temperature of 300 K and a pressure of 1 bar using 20-fs time steps. To control the temperature and pressure, the v-rescale thermostat (64) was used with a coupling constant τt = 1.0 ps together with the Parrinello-Rahman barostat (65) and a coupling constant of τp = 20.0 ps and compressibility of χ = 3.0 × 10−4 bar−1. Nonbonded interactions were treated with a dielectric constant of 15 and using a cutoff distance of 1.1 nm. Visual Molecular Dynamics (VMD) was used for visualization (66).
For many simulations, the Martini 2.2. force field was modified to increase the P-W interaction, which was achieved by giving water beads their own atom type with a 5% larger C6 parameter in interactions with all other atom types, resulting in around 5% higher P-W interactions.
Parallel-biased metadynamics (37, 67), as implemented in PLUMED2 (68), was used to enhance the sampling of the conformational space, together with the multiple-walker approach (69) with 112 replicas for free polyubiquitin or 64 replicas for free NEMO as well as bound NEMO with Ub2, where each replica had a different starting conformation. The used collective variables were the distances between the centers of the different ubiquitin cores, a torsion angle between the centers of residues 1 to 36 and 37 to 70 of two different ubiquitins, the radius of gyration (calculated only with backbone atoms) and the alphabeta collective variable describing the torsional angles for linkers between the ubiquitin pairs. In total, 4 collective variables for Ub2, 9 for Ub3, and 16 for Ub4 were used. In the case of simulations with NEMO, additional collective variables were used for the shape of NEMO and distances between Ub2 and NEMO. The bias factor of the well-tempered metadynamics (70) was set to 10, the frequency for the hill addition was 200 (every 4 ps), the height of Gaussian hills was 0.1 kJ/mol for simulations with Ub2 and Ub3, 0.075 kJ/mol for simulations with tetraubiquitin and 0.02 kJ/mol for the simulation with NEMO bound to Ub2. The flexible Gaussian approach (71) was used to determine the Gaussian width during the simulation.
Metainference (36), a method based on Bayesian inference, was used to integrate experimental SAXS data into simulations and was coupled with metadynamics (M&M) (47). The calculation of the SAXS intensities from a CG Martini representation is implemented in the PLUMED-ISDB module (72, 73) using the parameters derived by Niebling et al. (74) and the Debye equation. The SAXS data of the different systems were fitted with a 16th-degree polynomial to calculate points used for restraints. Twenty-one equidistant points for q between 0.017 and 0.24 nm−1 were used for Ub2 and Ub3 and for free and bound NEMO, 19 points for q between 0.025 and 0.19 nm−1 for Ub4. The rage depends on the quality of the experimental data. An initial scaling value was determent by comparing the calculated and experimental SAXS intensities for the lowest q value. Metainference was used with the outlier noise model (36) for each data point, and the restraints were applied every fifth step. A scaling faction and offset for the experimental data were sampled using a flat prior between 0.9 and 1.1 or −1 and 1. The error for calculating an average quantity σmean was determined automatically (75) from the maximum SE over 2 ps of simulations.
Six different simulations with Ub2 were performed using: Martini 2.2 with metadynamics, with increased P-W interaction and metadynamics, with M&M, with M&M applied every step, and with Martini 3 beta. Notably, Martini 3 beta was not stable with metadynamics; therefore, 112 replicas were run on a longer time scale. The SAXS data of Ub2 were taken from Vincendeau et al. (23). Notably, the profile was measured with Ub2 containing a His-tag on the N terminus that was also modeled. Ub3 and Ub4 simulations were run with increased P-W interaction, metadynamics with and without metainference, and SAXS. All polyubiquitin simulations were run for at least 500 ns per replica. The simulations with free NEMO and NEMO bound to Ub2 were performed with increased P-W interaction and M&M with SAXS for at least 100 ns per replica. The SAXS data of NEMO bound to Ub2 were taken from Vincendeau et al. (23).
Five simulations were performed with a K63 Ub2 construct, using Martini 2.2 with +5% increased P-W interaction and metadynamics and with +5% increased P-W interactions and M&M, as well as two additional tests with +10% increased P-W interactions and a weaker elastic network with a force constant of 500 kJ mol−1 nm−2, using the same SAXS data and constructs as described in Paissoni et al. (48). In addition, two control simulations with K63 Ub2 were performed using a Martini bead–based excluding volume. The Martini nonbonded interactions were replaced with repulsion term. The plumed input files, as well as the modified Martini topology files, are deposited in PLUMED-NEST (76) as plumID:20.009.
Protein expression and purification
Human NEMO258–350 C347S was expressed and purified as described in Vincendeau et al. (23). Protein concentration was determined by measuring the absorbance at 205 nm using specific absorbance for NEMO258–350 C347S of 300,990 M−1 cm−1, respectively (77).
The constructs for the expression of Ub3 and Ub4 were a gift of P. Elliott and D. Komander [Medical Research Council (MRC) Laboratory of Molecular Biology, Cambridge, UK]. The constructs were transformed into Escherichia coli strain BL21 (DE3) and cultured at 20°C in 2-liter flasks containing 500 ml of ZYM 5052 autoinduction medium (78) and carbenicillin (100 μg/ml). Cells were harvested by centrifugation after reaching saturation, resuspended in 60-ml lysis buffer [50 mM tris-HCl, 300 mM NaCl, 10 mM MgCl2, deoxyribonuclease I (10 μg/ml), 1 mM AEBSF.HCl (4-(2-Aminoethyl)benzenesulfonyl fluoride hydrochloride), 0.2% (v/v) NP-40, and lysozyme (1 mg/ml; pH 8.0)], and lysed by sonication. The lysate was clarified by centrifugation (40,000g) and filtration (0.2 μM). The supernatant was heated in a water bath for 10 to 15 min at 60°C and the precipitate removed by centrifugation. The supernatant was dialyzed overnight against 2 liters of buffer A [50 mM sodium acetate (pH 4.5)], clarified by centrifugation and applied to a 5-ml HiTrap SP HP column (GE Healthcare), and equilibrated in buffer A. Bound proteins were eluted using a linear gradient (10 column volumes) from 0 to 1 M NaCl in buffer A using an Äkta Purifier (GE Healthcare). Elution fractions (1.6 ml) were collected in wells containing 250 μl of 1 M tris-HCl (pH 9.0). Fractions containing Ub3 or Ub4 were pooled, concentrated and applied to a HiLoad 16/600 Superdex 75 column (GE Healthcare), and equilibrated in buffer B [50 mM tris-HCl and 100 mM NaCl (pH 7.4)]. The main elution peak containing Ub3 or Ub4 was collected and concentrated to approximately 3 to 6 mg/ml, flash-frozen, and stored at −80°C. Protein concentrations were determined by measuring the absorbance at 205 nm using specific absorbance for Ub3 and Ub4 of 747,790 and 997,980 M−1 cm−1, respectively (77). The Ub4 concentration values used on interaction studies of Ub4 with NEMO were corrected by 30% on the basis of the SEC with SLS results.
Small-angle x-ray scattering measurements
SAXS measurements were performed on a Rigaku BioSAXS-1000 instrument with an HF007 microfocus generator equipped with a Cu target at 40 kV and 30 mA. Transmissions were measured with a photodiode beamstop, and q calibration was made by an Ag-behenate measurement. Absolute calibration was done with calibrated glassy carbon (79). Measurements were done in four 900-s frames, which were averaged. Under these conditions, no radiation damage was detected. Circular averaging and background subtraction were done with the Rigaku SAXSLab software v 3.0.1r1.
Radii of gyration were calculated with the ATSAS package v 2.8.0 (80). Fits for the MW determination were made in Origin v 9. SAXS measurements were made at 293 K using a buffer containing 300 mM NaCl and 50 mM tris-HCl at pH 8.0. Experiments on the free proteins were performed at the following concentrations (fig. S3, I and J): NEMO at 2.34, 4.62, and 7.72 mg/ml; Ub3 at 3.41, 6.72, and 11.17 mg/ml; and Ub4 at 4.5, 9.1 and 15.1 mg/ml. Experiments with NEMO and Ub3 and Ub4 at different ratios were performed at two concentrations (between 3 and 4 and 7 and 8 mg/ml) at the following ratios: NEMO:Ub3 at 1.4:1 and 2.7:1 ratios and NEMO:Ub4 at 1.0:1, 2.1:1, and 3.1:1 ratios. No concentration-dependent effects were detected.
Isothermal titration calorimetry
ITC measurements were carried out at 298 K using a PEAQ-ITC titration microcalorimeter (MicroCal, Malvern). The NEMO-to-Ub3 calorimetric titration consisted of 19 injections of 2 μl of a 2.13 mM NEMO solution, into the reaction cell containing 300 μl of 94.71 μM Ub3, at a stirring speed of 750 rpm. The NEMO-to-Ub4 calorimetric titration consisted of 19 injections of 2 μl of a 2.84 mM NEMO solution, into the reaction cell containing 300 μl of 120.6 μM Ub4, at a stirring speed of 750 rpm. Sample conditions were 50 mM sodium phosphate (pH 7.0) and 50 mM NaCl. The heat of dilution was obtained by titrating NEMO into the sample cell containing only buffer. Experiments were done in triplicate. The ITC data were analyzed using the software MicroCal PEAQ-ITC analysis software. Parameters are presented as averages ± SEs.
SEC with SLS
SLS experiments were performed of NEMO mutant (C347S) in complex with tri- and tetraubiquitin at 30°C using a Viscotek TDA 305 triple array detector (Malvern Instruments) downstream to an Äkta Purifier (GE Healthcare) equipped with an analytical size exclusion column (Superdex 200 10/300 GL, GE Healthcare) at 4°C. The samples were run at approximately 8 mg/ml at a flow rate of 0.5 ml/min. The experiments were performed using a tris buffer [50 mM tris-HCl and 300 mM NaCl (pH 8.0)] and a phosphate buffer [50 mM sodium phosphate and 50 mM NaCl (pH 7.0)]. The molecular masses of the samples were calculated from the refractive index and right-angle light-scattering signals using Omnisec (Malvern Instruments). The SLS detector was calibrated with a bovine serum albumin (BSA) solution (4 mg/ml) using 66.4 kDa for the BSA monomer and a dn/dc value of 0.185 ml/g for all protein samples.
SPR measurements
SPR measurements were performed at 25°C using a Pioneer FE instrument (FortéBio, Molecular Devices). Ub3 and Ub4 were covalently immobilized onto two different flow cell channels on a biosensor chip by amine coupling to 456 and 721 response unit, respectively, using a 10 mM NaOAc (pH 5) immobilization buffer. NEMO was injected in a twofold concentration series over immobilized ubiquitins at a flow rate of 30 μl/min using a phosphate-buffered saline running buffer [50 mM sodium phosphate, 50 mM NaCl, and 0.005% Tween 20 (pH 7)]. The data were analyzed using Qdat Data Analysis Tool version 2.6.3.0 (FortéBio). The sensorgrams were corrected for buffer effects and unspecific binding to the chip matrix by subtraction of blank and reference surface (a blank flow cell channel activated by injection of EDC/NHS (N-ethyl-N′-(3-dimethylaminopropyl)carbodiimide hydrochloride/N-hydroxysuccinimide) and inactivated by injection of ethanolamine). The equilibrium dissociation constants (KD) were estimated by plotting responses at equilibrium (Req) against the injected concentration and curve fitted to a Langmuir (1:1) binding isotherm.
Supplementary Material
Acknowledgments
We acknowledge P. Elliott and D. Komander (MRC Laboratory of Molecular Biology, Cambridge, UK) for the Ub3 and Ub4 plasmids. We acknowledge D. Krappmann (Helmholtz Zentrum München, Germany) for reading the paper and providing useful feedback. We acknowledge SAXS measurements at the facility of the SFB1035 at Department Chemie, Technische Universität München. Funding: A.J. and C.C. acknowledge support by the Technische Universität München–Institute for Advanced Study, funded by the German Excellence Initiative and the European Union Seventh Framework Programme under grant agreement no. 291763. M.S. acknowledges funding by the DFG SFB1035; S.M.Ø.S. and A.B. acknowledge the support by the Lundbeck Foundation (grant R190-2014-3710). We gratefully acknowledge the Gauss Centre for Supercomputing e.V. (www.gauss-centre.eu) for funding this project by providing computing time on the GCS Supercomputer SuperMUC at the Leibniz Supercomputing Center (LRZ; www.lrz.de). Author contributions: A.J., A.C.M., M.S., and C.C. designed the project. A.J. and C.C. developed the new computational method. A.J. performed the simulations. A.C.M. and A.G. performed the ITC and SEC + SLS experiments. R.S. performed the SAXS measurements. S.M.Ø.S. and A.B. performed the SPR measurements. C.P. was involved in the analysis of K63 Ub2 data. All authors analyzed the results. A.J., A.C.M., M.S., and C.C. wrote the manuscript with contributions from all other authors. Competing interests: The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials. The plumed input files and the modified Martini topology files are deposited in PLUMED-NEST (76) as plumID:20.009. Additional data related to this paper may be requested from the authors.
SUPPLEMENTARY MATERIALS
REFERENCES AND NOTES
- 1.Haglund K., Dikic I., Ubiquitylation and cell signaling. EMBO J. 24, 3353–3359 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Deshaies R. J., Joazeiro C. A., RING domain E3 ubiquitin ligases. Annu. Rev. Biochem. 78, 399–434 (2009). [DOI] [PubMed] [Google Scholar]
- 3.Li W., Ye Y., Polyubiquitin chains: Functions, structures, and mechanisms. Cell. Mol. Life Sci. 65, 2397–2406 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Peng J., Schwartz D., Elias J. E., Thoreen C. C., Cheng D., Marsischky G., Roelofs J., Finley D., Gygi S. P., A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 21, 921–926 (2003). [DOI] [PubMed] [Google Scholar]
- 5.Kirisako T., Kamei K., Murata S., Kato M., Fukumoto H., Kanie M., Sano S., Tokunaga F., Tanaka K., Iwai K., A ubiquitin ligase complex assembles linear poly-ubiquitin chains. EMBO J. 25, 4877–4887 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Iwai K., Tokunaga F., Linear polyubiquitination: A new regulator of NF-kappaB activation. EMBO Rep. 10, 706–713 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Iwai K., Fujita H., Sasaki Y., Linear ubiquitin chains: NF-kappaB signalling, cell death and beyond. Nat. Rev. Mol. Cell Biol. 15, 503–508 (2014). [DOI] [PubMed] [Google Scholar]
- 8.Komander D., Rape M., The ubiquitin code. Annu. Rev. Biochem. 81, 203–229 (2012). [DOI] [PubMed] [Google Scholar]
- 9.Zhao S., Ulrich H. D., Distinct consequences of posttranslational modification by linear versus K63-linked poly-ubiquitin chains. Proc. Natl. Acad. Sci. U.S.A. 107, 7704–7709 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Fushman D., Wilkinson K. D., Structure and recognition of poly-ubiquitin chains of different lengths and linkage. F1000 Biol. Rep. 3, 26 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Akutsu M., Dikic I., Bremm A., Ubiquitin chain diversity at a glance. J. Cell Sci. 129, 875–880 (2016). [DOI] [PubMed] [Google Scholar]
- 12.Thrower J. S., Hoffman L., Rechsteiner M., Pickart C. M., Recognition of the poly-ubiquitin proteolytic signal. EMBO J. 19, 94–102 (2000). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Tsuchiya H., Ohtake F., Arai N., Kaiho A., Yasuda S., Tanaka K., Saeki Y., In vivo ubiquitin linkage-type analysis reveals that the Cdc48-Rad23/Dsk2 axis contributes to K48-linked chain specificity of the proteasome. Mol. Cell 66, 488–502.e7 (2017). [DOI] [PubMed] [Google Scholar]
- 14.von Delbruck M., Kniss A., Rogov V. V., Pluska L., Bagola K., Lohr F., Guntert P., Sommer T., Dötsch V., The CUE domain of Cue1 aligns growing ubiquitin chains with Ubc7 for rapid elongation. Mol. Cell 62, 918–928 (2016). [DOI] [PubMed] [Google Scholar]
- 15.Pierce N. W., Kleiger G., Shan S. O., Deshaies R. J., Detection of sequential polyubiquitylation on a millisecond timescale. Nature 462, 615–619 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Kovacev J., Wu K., Spratt D. E., Chong R. A., Lee C., Nayak J., Shaw G. S., Pan Z. Q., A snapshot of ubiquitin chain elongation: Lysine 48-tetra-ubiquitin slows down ubiquitination. J. Biol. Chem. 289, 7068–7081 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Gerlach B., Cordier S. M., Schmukle A. C., Emmerich C. H., Rieser E., Haas T. L., Webb A. I., Rickard J. A., Anderton H., Wong W. W., Nachbur U., Gangoda L., Warnken U., Purcell A. W., Silke J., Walczak H., Linear ubiquitination prevents inflammation and regulates immune signalling. Nature 471, 591–596 (2011). [DOI] [PubMed] [Google Scholar]
- 18.Wertz I. E., Newton K., Seshasayee D., Kusam S., Lam C., Zhang J., Popovych N., Helgason E., Schoeffler A., Jeet S., Ramamoorthi N., Kategaya L., Newman R. J., Horikawa K., Dugger D., Sandoval W., Mukund S., Zindal A., Martin F., Quan C., Tom J., Fairbrother W. J., Townsend M., Warming S., DeVoss J., Liu J., Dueber E., Caplazi P., Lee W. P., Goodnow C. C., Balazs M., Yu K., Kolumam G., Dixit V. M., Phosphorylation and linear ubiquitin direct A20 inhibition of inflammation. Nature 528, 370–375 (2015). [DOI] [PubMed] [Google Scholar]
- 19.Senft D., Qi J., Ronai Z. A., Ubiquitin ligases in oncogenic transformation and cancer therapy. Nat. Rev. Cancer 18, 69–88 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Catici D. A., Horne J. E., Cooper G. E., Pudney C. R., Polyubiquitin drives the molecular interactions of the NF-kappaB essential modulator (NEMO) by allosteric regulation. J. Biol. Chem. 290, 14130–14139 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Hauenstein A. V., Xu G., Kabaleeswaran V., Wu H., Evidence for M1-Linked polyubiquitin-mediated conformational change in NEMO. J. Mol. Biol. 429, 3793–3800 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Hinz M., Scheidereit C., The IκB kinase complex in NF-κB regulation and beyond. EMBO Rep. 15, 46–61 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Vincendeau M., Hadian K., Messias A. C., Brenke J. K., Halander J., Griesbach R., Greczmiel U., Bertossi A., Stehle R., Nagel D., Demski K., Velvarska H., Niessing D., Geerlof A., Sattler M., Krappmann D., Inhibition of canonical NF-kappaB signaling by a small molecule targeting NEMO-ubiquitin interaction. Sci. Rep. 6, 18934 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Rahighi S., Ikeda F., Kawasaki M., Akutsu M., Suzuki N., Kato R., Kensche T., Uejima T., Bloor S., Komander D., Randow F., Wakatsuki S., Dikic I., Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 136, 1098–1109 (2009). [DOI] [PubMed] [Google Scholar]
- 25.Ivins F. J., Montgomery M. G., Smith S. J., Morris-Davies A. C., Taylor I. A., Rittinger K., NEMO oligomerization and its ubiquitin-binding properties. Biochem. J. 421, 243–251 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Polley S., Huang D. B., Hauenstein A. V., Fusco A. J., Zhong X., Vu D., Schrofelbauer B., Kim Y., Hoffmann A., Verma I. M., Ghosh G., Huxford T., A structural basis for IkappaB kinase 2 activation via oligomerization-dependent trans auto-phosphorylation. PLOS Biol. 11, e1001581 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.DiDonato J. A., Hayakawa M., Rothwarf D. M., Zandi E., Karin M., A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB. Nature 388, 548–554 (1997). [DOI] [PubMed] [Google Scholar]
- 28.Thach T. T., Shin D., Han S., Lee S., New conformations of linear poly-ubiquitin chains from crystallographic and solution-scattering studies expand the conformational space of poly-ubiquitin. Acta Crystallogr. D Struct. Biol. 72, 524–535 (2016). [DOI] [PubMed] [Google Scholar]
- 29.Boldon L., Laliberte F., Liu L., Review of the fundamental theories behind small angle x-ray scattering, molecular dynamics simulations, and relevant integrated application. Nanotechnol. Rev. 6, 25661 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Zuckerman D. M., Equilibrium sampling in biomolecular simulations. Annu. Rev. Biophys. 40, 41–62 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Camilloni C., Pietrucci F., Advanced simulation techniques for the thermodynamic and kinetic characterization of biological systems. Adv. Phys. X 3, 1477531 (2018). [Google Scholar]
- 32.Kmiecik S., Gront D., Kolinski M., Wieteska L., Dawid A. E., Kolinski A., Coarse-grained protein models and their applications. Chem. Rev. 116, 7898–7936 (2016). [DOI] [PubMed] [Google Scholar]
- 33.Bonomi M., Heller G. T., Camilloni C., Vendruscolo M., Principles of protein structural ensemble determination. Curr. Opin. Struct. Biol. 42, 106–116 (2017). [DOI] [PubMed] [Google Scholar]
- 34.Marrink S. J., Risselada H. J., Yefimov S., Tieleman D. P., de Vries A. H., The MARTINI force field: Coarse grained model for biomolecular simulations. J. Phys. Chem. B 111, 7812–7824 (2007). [DOI] [PubMed] [Google Scholar]
- 35.de Jong D. H., Singh G., Bennett W. F., Arnarez C., Wassenaar T. A., Schafer L. V., Periole X., Tieleman D. P., Marrink S. J., Improved parameters for the Martini coarse-grained protein force field. J. Chem. Theory Comput. 9, 687–697 (2013). [DOI] [PubMed] [Google Scholar]
- 36.Bonomi M., Camilloni C., Cavalli A., Vendruscolo M., Metainference: A Bayesian inference method for heterogeneous systems. Sci. Adv. 2, e1501177 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Laio A., Parrinello M., Escaping free-energy minima. Proc. Natl. Acad. Sci. U.S.A. 99, 12562–12566 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Komander D., Reyes-Turcu F., Licchesi J. D., Odenwaelder P., Wilkinson K. D., Barford D., Molecular discrimination of structurally equivalent Lys 63-linked and linear poly-ubiquitin chains. EMBO Rep. 10, 466–473 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Rohaim A., Kawasaki M., Kato R., Dikic I., Wakatsuki S., Structure of a compact conformation of linear diubiquitin. Acta Crystallogr. D Biol. Crystallogr. 68, 102–108 (2012). [DOI] [PubMed] [Google Scholar]
- 40.Stark A. C., Andrews C. T., Elcock A. H., Toward optimized potential functions for protein-protein interactions in aqueous solutions: Osmotic second virial coefficient calculations using the MARTINI coarse-grained force field. J. Chem. Theory Comput. 9, 4176–4185 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Javanainen M., Martinez-Seara H., Vattulainen I., Excessive aggregation of membrane proteins in the Martini model. PLOS ONE 12, e0187936 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Berg A., Kukharenko O., Scheffner M., Peter C., Towards a molecular basis of ubiquitin signaling: A dual-scale simulation study of ubiquitin dimers. PLOS Comput. Biol. 14, e1006589 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Larsen A. H., Wang Y., Bottaro S., Grudinin S., Arleth L., Lindorff-Larsen K., Combining molecular dynamics simulations with small-angle x-ray and neutron scattering data to study multi-domain proteins in solution. PLoS Comput. Biol. 16, e1007870 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Yesylevskyy S. O., Schafer L. V., Sengupta D., Marrink S. J., Polarizable water model for the coarse-grained MARTINI force field. PLOS Comput. Biol. 6, e1000810 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Gotz A. W., Bucher D., Lindert S., McCammon J. A., Dipeptide aggregation in aqueous solution from fixed point-charge force fields. J. Chem. Theory Comput. 10, 1631–1637 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Robustelli P., Piana S., Shaw D. E., Developing a molecular dynamics force field for both folded and disordered protein states. Proc. Natl. Acad. Sci. U.S.A. 115, E4758–E4766 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Bonomi M., Camilloni C., Vendruscolo M., Metadynamic metainference: Enhanced sampling of the metainference ensemble using metadynamics. Sci. Rep. 6, 31232 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Paissoni C., Jussupow A., Camilloni C., Determination of protein structural ensembles by hybrid-resolution SAXS restrained molecular dynamics. J. Chem. Theory Comput. 16, 2825–2834 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Bhattacharjee S. M., Giacometti A., Maritan A., Flory theory for polymers. J. Phys. Condens. Matter 25, 503101 (2013). [DOI] [PubMed] [Google Scholar]
- 50.Castaneda C. A., Kashyap T. R., Nakasone M. A., Krueger S., Fushman D., Unique structural, dynamical, and functional properties of k11-linked poly-ubiquitin chains. Structure 21, 1168–1181 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Berlin K., Castaneda C. A., Schneidman-Duhovny D., Sali A., Nava-Tudela A., Fushman D., Recovering a representative conformational ensemble from underdetermined macromolecular structural data. J. Am. Chem. Soc. 135, 16595–16609 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Lin S. M., Lin S. C., Hong J. Y., Su T. W., Kuo B. J., Chang W. H., Tu Y. F., Lo Y. C., Structural insights into linear tri-ubiquitin recognition by A20-binding inhibitor of NF-kappaB, ABIN-2. Structure 25, 66–78 (2017). [DOI] [PubMed] [Google Scholar]
- 53.Liu Z., Tang C., Ensemble structure description of Lys63-linked diubiquitin. Data Brief 7, 81–88 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Liu Z., Gong Z., Jiang W. X., Yang J., Zhu W. K., Guo D. C., Zhang W. P., Liu M. L., Tang C., Lys63-linked ubiquitin chain adopts multiple conformational states for specific target recognition. eLife 4, e05767 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Wang Y., Tang C., Wang E., Wang J., PolyUbiquitin chain linkage topology selects the functions from the underlying binding landscape. PLOS Comput. Biol. 10, e1003691 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Ye Y., Blaser G., Horrocks M. H., Ruedas-Rama M. J., Ibrahim S., Zhukov A. A., Orte A., Klenerman D., Jackson S. E., Komander D., Ubiquitin chain conformation regulates recognition and activity of interacting proteins. Nature 492, 266–270 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Bremm A., Freund S. M., Komander D., Lys11-linked ubiquitin chains adopt compact conformations and are preferentially hydrolyzed by the deubiquitinase Cezanne. Nat. Struct. Mol. Biol. 17, 939–947 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Tenno T., Fujiwara K., Tochio H., Iwai K., Morita E. H., Hayashi H., Murata S., Hiroaki H., Sato M., Tanaka K., Shirakawa M., Structural basis for distinct roles of Lys63- and Lys48-linked poly-ubiquitin chains. Genes Cells 9, 865–875 (2004). [DOI] [PubMed] [Google Scholar]
- 59.Berg A., Franke L., Scheffner M., Peter C., Machine learning driven analysis of large scale simulations reveals conformational characteristics of ubiquitin chains. J. Chem. Theory Comput. 16, 3205–3220 (2020). [DOI] [PubMed] [Google Scholar]
- 60.Hadian K., Griesbach R. A., Dornauer S., Wanger T. M., Nagel D., Metlitzky M., Beisker W., Schmidt-Supprian M., Krappmann D., NF-κB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-κB activation. J. Biol. Chem. 286, 26107–26117 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Crabtree M. D., Borcherds W., Poosapati A., Shammas S. L., Daughdrill G. W., Clarke J., Conserved helix-flanking prolines modulate intrinsically disordered protein: Target affinity by altering the lifetime of the bound complex. Biochemistry 56, 2379–2384 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 62.Abraham M. J., Murtola T., Schulz R., Páll S., Smith J. C., Hess B., Lindahl E., GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1-2, 19–25 (2015). [Google Scholar]
- 63.Periole X., Cavalli M., Marrink S. J., Ceruso M. A., Combining an elastic network with a coarse-grained molecular force field: Structure, dynamics, and intermolecular recognition. J. Chem. Theory Comput. 5, 2531–2543 (2009). [DOI] [PubMed] [Google Scholar]
- 64.Bussi G., Donadio D., Parrinello M., Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007). [DOI] [PubMed] [Google Scholar]
- 65.Parrinello M., Rahman A., Polymorphic transitions in single crystals: A new molecular dynamics method. J. Appl. Phys. 52, 7182–7190 (1981). [Google Scholar]
- 66.Humphrey W., Dalke A., Schulten K., VMD: Visual molecular dynamics. J. Mol. Graph. 14, 33–38 (1996). [DOI] [PubMed] [Google Scholar]
- 67.Pfaendtner J., Bonomi M., Efficient sampling of high-dimensional free-energy landscapes with parallel Bias Metadynamics. J. Chem. Theory Comput. 11, 5062–5067 (2015). [DOI] [PubMed] [Google Scholar]
- 68.Tribello G. A., Bonomi M., Branduardi D., Camilloni C., Bussi G., PLUMED 2: New feathers for an old bird. Comput. Phys. Commun. 185, 604–613 (2014). [Google Scholar]
- 69.Raiteri P., Laio A., Gervasio F. L., Micheletti C., Parrinello M., Efficient reconstruction of complex free energy landscapes by multiple walkers metadynamics. J. Phys. Chem. B 110, 3533–3539 (2006). [DOI] [PubMed] [Google Scholar]
- 70.Barducci A., Bussi G., Parrinello M., Well-tempered metadynamics: a smoothly converging and tunable free-energy method. Phys. Rev. Lett. 100, 020603 (2008). [DOI] [PubMed] [Google Scholar]
- 71.Branduardi D., Bussi G., Parrinello M., Metadynamics with adaptive Gaussians. J. Chem. Theory Comput. 8, 2247–2254 (2012). [DOI] [PubMed] [Google Scholar]
- 72.Bonomi M., Camilloni C., Integrative structural and dynamical biology with PLUMED-ISDB. Bioinformatics 33, 3999–4000 (2017). [DOI] [PubMed] [Google Scholar]
- 73.Paissoni C., Jussupow A., Camilloni C., Martini bead form factors for nucleic acids and their application in the refinement of protein–nucleic acid complexes against SAXS data. J. Appl. Crystallogr. 52, 394–402 (2019). [Google Scholar]
- 74.Niebling S., Bjorling A., Westenhoff S., MARTINI bead form factors for the analysis of time-resolved x-ray scattering of proteins. J. Appl. Crystallogr. 47, 1190–1198 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 75.Löhr T., Jussupow A., Camilloni C., Metadynamic metainference: Convergence towards force field independent structural ensembles of a disordered peptide. J. Chem. Phys. 146, 165102 (2017). [DOI] [PubMed] [Google Scholar]
- 76.The PLUMED consortium , Promoting transparency and reproducibility in enhanced molecular simulations. Nat. Methods 16, 670–673 (2019). [DOI] [PubMed] [Google Scholar]
- 77.Anthis N. J., Clore G. M., Sequence-specific determination of protein and peptide concentrations by absorbance at 205 nm. Protein Sci. 22, 851–858 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 78.Studier F. W., Protein production by auto-induction in high-density shaking cultures. Protein Expr. Purif. 41, 207–234 (2005). [DOI] [PubMed] [Google Scholar]
- 79.Fan L., Degen M., Bendle S., Grupido N., Ilavsky J., The absolute calibration of a small-angle scattering instrument with a laboratory x-ray source. J. Phys. Conf. Ser. 247, 012005 (2010). [Google Scholar]
- 80.Petoukhov M. V., Franke D., Shkumatov A. V., Tria G., Kikhney A. G., Gajda M., Gorba C., Mertens H. D., Konarev P. V., Svergun D. I., New developments in the ATSAS program package for small-angle scattering data analysis. J. Appl. Crystallogr. 45, 342–350 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.